SSJ_Peprotech_Order_June_2018.pdf
PDF 510 KB Posted
- Attached to
- Peprotech Cell Growth Cytokines Federal contract opportunity
- Solicitation number
- NIHDA201800289
About this file
Sole Source Justification Peprotech
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| Purchase_Product_Systems_Equipment_Description_Peprotech_2018.pdf |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Revised10/31/2016
FAR Subpart 13.106-1(b)
SOLE-SINGLE SOURCE (including Brand-Name) JUSTIFICATION
“Source Selection Information – see FAR 2.101 and 3.104”
1. Identification of the Agency and Contracting Activity.
a. Federal Agency and Contracting Activity.
Department of Health and Human Services
National Institute of Health
National Institute on Drug Abuse
b. Sponsoring Organization. NIH/NIA/IRP/TGB/EGS/ESC
c. Project Officer Information.
• Project Officer Name. Julie Mattison, Ph.D.
• Mailing Address. 16701 Elmer School Road, Dickerson, MD 20842
• E-mail Address. mattisonj@mail.nih.gov
• Telephone Number. 301-435-7637
2. Project Description.
a. Name of Item or Project Title. Cytokines for culturing stem cells
b. Description of the Item or Service.
Purchase of various cytokines required to maintain hematopoietic stem cells (HSC’s) in culture. This research aims to further develop the in-vitro model of how HSCs age.
Peprotech products have been used in previous publications, and it is essential that the reagents for cell culture remain the same in order to obtain consistent results.
3. Market Research (see FAR Part 1 0).
Market Research was conducted and the results of market research are detailed in the attached market research document.
4. Acquisition Type.
This acquisition exceeds $3,500 and not expected to exceed $150,000, and conducted in accordance with FAR Part 13—Simplified Acquisition Procedures.
5. Acquisition Authority. This acquisition is conducted under the authority of the Federal
Acquisition Regulations (FAR) Subpart 13.106-1 (b) Soliciting from a single source. (1)
For purchases not exceeding the simplified acquisition threshold, contracting officers may solicit from one source if the contracting officer determines that the circumstances mailto:mattisonj@mail.nih.gov of the contract action deem only one source reasonably available (e.g., urgency, exclusive licensing agreements, or industrial mobilization).
6. Justification Rationale.
Brand-name or Items peculiar to one manufacturer:
The essential characteristics of these cytokines that limit the availability to a sole source are that these reagents have been used since the commencement of the project. Only this suggested source can furnish the requirements, to the exclusion of other sources, because continuous use of the same lots of them are required for successful completion of the projects that are ongoing.
7. Any other facts supporting the justification. Initial projects in the Dr. Isabel Beerman’s lab (Project officer) would be a continuation of her postdoctoral research aims which has been carried out for over 7 years. Keeping the reagents like cytokines especially for key cell culture experiments is of utmost importance to maintain the consistency and reproducibility of the ongoing part of the projects.
These reagents have been used since the commencement of the project and continuous use of the same lots of them are required for successful completion of the projects that are ongoing.
7. Project Officer Certification. The undersigned program official(s) certifies that the information in support of this justification for the proposed acquisition has been reviewed, is completed and correct to the best of my knowledge and belief and recommends approval.
6/15/2018
X Julie Mattison
Signed by: Julie A. Mattison -A
Project Officer Date
8. Contracting Officer Certification. The Contracting Officer certifies that the justification for the proposed acquisition has been reviewed and that to the best of my knowledge and belief the information and/or data provided to support the rationale and recommendation for approval is accurate and complete and in accordance with FAR
13.106-1(b)(1), the facts of this acquisition preclude the use of full and open competition.
Contracting Officer Date
| 2018-06-30T11:36:37-0400 | |
| Jon J. Gottschalk -S |
File details come from the government source that posted it.